Market Tracker

08/19 6:05pm ET

Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

160.80
Data as of Aug 19
 +21.63 / +15.54%
Today’s Change
64.93
Today|||52-Week Range
162.38
+78.79%
Year-to-Date

Today’s Trading

Previous close139.17
Today’s open139.03
Day’s range138.17 - 162.38
Volume6,756,359
Average volume (3 months)1,246,003
Market cap$8.9B
Dividend yield--
Data as of 3:59pm ET, 08/19/2014

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+65.28%
Earnings growth (next 5 years)+18.40%
Revenue growth (last year)+26.98%
P/E ratio191.4
Price/Sales5.95
Price/Book11.82

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+0.44+0.85%
PCYCPharmacyclics Inc-1.88-1.54%
JAZZJazz Pharmaceuticals...+4.36+2.86%
HSPHospira Inc-1.56-2.81%
Data as of 4:00pm ET, 08/19/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)$1.58
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Carolyn J. Logan
CFO, Executive VP-Finance &
Administration
Adam C. Derbyshire
Corporate headquarters
Raleigh, North Carolina

Forecasts